» Articles » PMID: 28060857

Pseudomonas Aeruginosa Ventilator-Associated Pneumonia Induces Lung Injury Through TNF-α/c-Jun NH2-Terminal Kinase Pathways

Overview
Journal PLoS One
Date 2017 Jan 7
PMID 28060857
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Ventilator-associated pneumonia (VAP) is a common nosocomial infection among intensive care unit (ICU) patients. Pseudomonas aeruginosa (PA) is the most common multidrug-resistant Gram-negative pathogen and VAP caused by PA carries a high rate of morbidity and mortality. This study examined the molecular mechanism of PA VAP-induced lung injury. C57BL/6 wild-type (WT) mice and JNK1 knockout (JNK1-/-) mice received mechanical ventilation (MV) for 3 h at 2 days after receiving nasal instillation of PA. The WT and JNK1-/- mice also received MV after the induction of lung injury by instillation of supernatants from PA-stimulated alveolar macrophages (AMs). AMs isolated from WT, IκB-kinase (IKK)βΔMye (IKKβ was selectively deleted in macrophages), and JNK1-/- mice were ex vivo stimulated with live PA and supernatants were collected for cytokine assay. Intranasal instillation of 106 PA enhanced MV-induced NF-κB DNA binding activity in the lungs and nitrite levels in BALF. MV after PA instillation significantly increased the expression of ICAM and VCAM in the lungs and TNF-α, IL-1β, and IL-6 levels in bronchoalveolar lavage fluid (BALF) of WT mice, but not in JNK1-/- mice. MV after supernatant instillation induced more total protein concentration in BALF and neutrophil sequestration in the lungs in WT mice than JNK1-/- mice and cytokine assay of supernatants indicated that TNF-α is a critical regulator of PA VAP-induced lung injury. Ex vivo PA stimulation induced TNF-α production by AMs from WT as well as JNK1-/- mice but not IKKβΔMye mice. In summary, PA colonization plays an important role in PA VAP-induced lung injury through the induction of JNK1-mediated inflammation. These results suggest that the pathogenesis mechanism of PA VAP involves production of TNF-α through activation of IKK/NF-κB pathways in AMs and JNK signaling pathway in the lungs.

Citing Articles

Unveiling Ventilator-Associated Pneumonia: S100A8 as a Promising Biomarker Through Integrated RNA-Seq Analysis.

Wang Q, Dong J, Jing X, Long Y, Jia H, Li Y J Multidiscip Healthc. 2025; 17:6199-6210.

PMID: 39759083 PMC: 11697655. DOI: 10.2147/JMDH.S495121.


Resistance in : A Narrative Review of Antibiogram Interpretation and Emerging Treatments.

Giovagnorio F, De Vito A, Madeddu G, Parisi S, Geremia N Antibiotics (Basel). 2023; 12(11).

PMID: 37998823 PMC: 10669487. DOI: 10.3390/antibiotics12111621.


Synergistic Antibiofilm Action of and Brazilian Green Propolis Hydroethanolic Extracts against Multidrug-Resistant Strains of and and Their Biocompatibility on Human Keratinocytes.

Meccatti V, Martins K, Ramos L, Pereira T, de Menezes R, Marcucci M Molecules. 2023; 28(19).

PMID: 37836747 PMC: 10574440. DOI: 10.3390/molecules28196904.


Antimicrobial Solutions for Endotracheal Tubes in Prevention of Ventilator-Associated Pneumonia.

Marcut L, Manescu Paltanea V, Antoniac A, Paltanea G, Robu A, Mohan A Materials (Basel). 2023; 16(14).

PMID: 37512308 PMC: 10386556. DOI: 10.3390/ma16145034.


Exploring the Nursing Factors Related to Ventilator-Associated Pneumonia in the Intensive Care Unit.

Yin Y, Sun M, Li Z, Bu J, Chen Y, Zhang K Front Public Health. 2022; 10:715566.

PMID: 35462831 PMC: 9019058. DOI: 10.3389/fpubh.2022.715566.


References
1.
El Solh A, Alhajhusain A . Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother. 2009; 64(2):229-38. DOI: 10.1093/jac/dkp201. View

2.
Nemzek J, Xiao H, Minard A, Bolgos G, Remick D . Humane endpoints in shock research. Shock. 2003; 21(1):17-25. DOI: 10.1097/01.shk.0000101667.49265.fd. View

3.
Budweiser S, Jorres R, Pfeifer M . Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2009; 3(4):605-18. PMC: 2650592. DOI: 10.2147/copd.s3814. View

4.
Francois B, Luyt C, Dugard A, Wolff M, Diehl J, Jaber S . Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial. Crit Care Med. 2012; 40(8):2320-6. DOI: 10.1097/CCM.0b013e31825334f6. View

5.
Mora A, Torres-Gonzalez E, Rojas M, Corredor C, Ritzenthaler J, Xu J . Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol. 2006; 35(4):466-73. PMC: 2643265. DOI: 10.1165/rcmb.2006-0121OC. View